Key populations brief
Accessed November 2017
Working Document, September 2017
Scientific advice
Prevention and control of communicable diseases in prison settings.
Blueprint for EECA countries, first edition
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
The Community Action Research on Disability (CARD) programme in Uganda embraced and modified the EDR approach, recognising the need for including people with disability in the research process from concept to outcome, and nurturing participation and collaboration between all the stakeholders in achi...eving action-based research. T
more
Where must I go if I feel unwell or have had an accident? Is medical treatment free in Switzerland or must I pay for it? What should I do in an emergency? What types of insurance do I need? How can I protect myself from illness? Where can I find health information in my own language? The Health Guid...e to Switzerland answers these and many other qüstions. Available in 18 languages: Albanian, Arabic, English, French, German, Italian, Croatian/Serbian/Bosnian, Portugüse, Spanish, Russian, Turkish, Thai, Tamil, Tigrinya, Vietnamese, Urdu, Farsi, Somali. For other languages check following link: http://www.migesplus.ch/publikationen/gesundheitsversorgung/show/gesundheitswegweiser-schweiz-3-komplett-überarbeitete-auflage/
more
2nd edition.
The practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
Topics in Antiviral Medicine Volume 25 Issue 2 May/June 2017
Supplement Article
J Acquir Immune Defic Syndr Volume 75, Supplement 2, June 1, 2017 www.jaids.com
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Lessons from the STEP-TB Project.
Accessed November 2017.
Doc. No.: INS/GDL/001-(Annexes)
National Tuberculosis and Leprosy Conrol Programme
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more